Squamous cell carcinoma of the head and neck has been the subject of sustained clinical investigation across multiple research sites.

23 total trials for this combination

Showing top 10 of 23 trials

Trials

NCT ID	Title	Status	Phase
NCT04881045	Study to Test the Safety and Tolerability of PF-07257876 in Participants With Selected Advanced Tumors.	COMPLETED	PHASE1
NCT03752398	A Study of XmAb®23104 in Subjects With Selected Advanced Solid Tumors (DUET-3)	COMPLETED	PHASE1
NCT02105636	Trial of Nivolumab vs Therapy of Investigator's Choice in Recurrent or Metastatic Head and Neck Carcinoma (CheckMate 141)	COMPLETED	PHASE3
NCT04590963	Assessment of Efficacy and Safety of Monalizumab Plus Cetuximab Compared to Placebo Plus Cetuximab in Recurrent or Metastatic Head and Neck Cancer	ACTIVE_NOT_RECRUITING	PHASE3
NCT03517488	A Study of XmAb®20717 in Subjects With Selected Advanced Solid Tumors	COMPLETED	PHASE1
NCT03454451	CPI-006 Alone and in Combination With Ciforadenant and With Pembrolizumab for Patients With Advanced Cancers	COMPLETED	PHASE1
NCT02952586	Study To Compare Avelumab In Combination With Standard of Care Chemoradiotherapy (SoC CRT) Versus SoC CRT for Definitive Treatment In Patients With Locally Advanced Squamous Cell Carcinoma Of The Head And Neck (JAVELIN HEAD AND NECK 100)	TERMINATED	PHASE3
NCT05783622	Study of JANX008 in Subjects With Advanced or Metastatic Solid Tumor Malignancies	RECRUITING	PHASE1
NCT03849469	A Study of XmAb®22841 Monotherapy & in Combination w/ Pembrolizumab in Subjects w/ Selected Advanced Solid Tumors	COMPLETED	PHASE1
NCT03349710	Nivolumab or Nivolumab Plus Cisplatin, in Combination With Radiotherapy in Patients With Cisplatin-ineligible or Eligible Locally Advanced Squamous Cell Head and Neck Cancer	COMPLETED	PHASE3

Related Pages

All Squamous cell carcinoma of the head and neck trials All trials in Pittsburgh, United States